SQLite Web: event_store.db

Update row sig_a42af42774fe in signals

id

Primary key. TEXT

event_id

TEXT NOT NULL

watcher_id

TEXT

signal_type

TEXT NOT NULL

value

{"aggregator_url":"https://www.sec.gov/Archives/edgar/data/1359931/0001213900-26-042079.txt","as_of":"2026-04-10T03:04:31.796915+00:00","canonical_url":"https://www.sec.gov/Archives/edgar/data/1359931/0001213900-26-042079.txt","company":"Protara Therapeutics, Inc.","enrichment":{"aggregator_url":"https://www.sec.gov/Archives/edgar/data/1359931/0001213900-26-042079.txt","article_chars":1821,"article_truncated":false,"blocked_reason":null,"candidate_id":"sc_879c959cefba0af6","canonical_host":"sec.gov","canonical_is_aggregator":false,"canonical_url":"https://www.sec.gov/Archives/edgar/data/1359931/0001213900-26-042079.txt","content_type":"text/plain","enriched_at":"2026-04-10T03:27:26.599135+00:00","extraction_method":"heuristic","fetched_description":"","fetched_title":"","final_url":"https://www.sec.gov/Archives/edgar/data/1359931/0001213900-26-042079.txt","html_truncated":false,"paywall_likely":false,"publisher_domain":"sec.gov","publisher_resolution":"canonical_url","requested_url":"https://www.sec.gov/Archives/edgar/data/1359931/0001213900-26-042079.txt","source_event_id":"evt_45fae7ce826a","source_quality":"medium","status_code":200,"version":"signal_enrichment_v2"},"form_type":"4","fp":"ab47a80c87823898","kind":"sec_filing","published_at":"20260409","publisher_domain":"sec.gov","signal_understanding":{"analysis_basis":"article","claim_confidence":0.72,"dates_mentioned":["2026-04-09","2026-04-08","2025-12-31","2026-04-10T03:04:31.796915+00:00"],"entities":[{"asset_class":"equity","name":"Protara Therapeutics, Inc.","relevance":"high","symbol":"TARA","type":"issuer"},{"asset_class":"person","name":"Jacqueline Zummo","relevance":"high","symbol":"","type":"reporting_person"},{"asset_class":"legal","name":"Rule 10b5-1 trading plan","relevance":"medium","symbol":"","type":"legal_instrument"}],"event_type":"other","information_gaps":["The provided text does not clearly include the specific number of shares and/or price details for the reported transaction (only partial numeric fragments like \u201c1134\u201d and \u201c5.40\u201d appear without full context).","The signal indicates \u201cTARA filed 4,\u201d but the exact change vs prior known state is not provided in the text (no prior filing comparison content included).","No explicit description of whether the transaction was a sale vs other action beyond the sentence stating \u201cThe sale reported on this Form 4 occurred automatically\u2026\u201d; the exact transaction type and totals are not fully extractable from the cleaned text."],"key_facts":["SEC filing type: Form 4 (CONFORMED SUBMISSION TYPE: 4).","Issuer: Protara Therapeutics, Inc. (issuer company conform ed name: Protara Therapeutics, Inc.).","Reporting person: Jacqueline Zummo; title shown as Chief R&D Officer.","Conformed period of report: 20260408; filed as of date: 20260409.","The filing states: \u201cThe sale reported on this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan established by the reporting person on December 31, 2025.\u201d","Signature line: \u201c/s/ Jacqueline Zummo\u201d with date 2026-04-09."],"numeric_claims":[{"label":"Rule 10b5-1 plan established date","value":"2025-12-31"},{"label":"Conformed period of report","value":"2026-04-08"},{"label":"Filed as of date","value":"2026-04-09"}],"primary_claim":"A Form 4 was filed on 2026-04-09 by Protara Therapeutics, Inc. reporting that Jacqueline Zummo\u2019s reported sale occurred automatically under a Rule 10b5-1 trading plan established on December 31, 2025.","relevance_score":0.55,"sentiment":"neutral","source_quality":"medium","summary":"Protara Therapeutics, Inc. (TARA) filed a Form 4 on 2026-04-09 reporting a transaction by reporting person Jacqueline Zummo (Chief R&D Officer). The filing states the sale occurred automatically under a Rule 10b5-1 trading plan established on 2025-12-31.","topics":["SEC Form 4","insider transaction","Rule 10b5-1","Protara Therapeutics","TARA"]},"source":"sec_edgar","source_domain":"sec.gov","summary":"Form 4 \u00b7 Protara Therapeutics, Inc. \u00b7 Filed 20260409","ticker":"TARA","tickers":["TARA"],"title":"TARA filed 4","url":"https://www.sec.gov/Archives/edgar/data/1359931/0001213900-26-042079.txt"}

TEXT NOT NULL

threshold

TEXT

direction

TEXT

severity

TEXT

window

TEXT

source

TEXT NOT NULL

reason_trace

TEXT

dedupe_key

TEXT NOT NULL

throttle_s

INTEGER (default 0

created_at

TEXT NOT NULL (default strftime('%Y-%m-%dT%H:%M:%fZ','now')

Cancel